| Drugs by Condition |  |
Osteosarcoma
Definition: Osteosarcoma is a malignant bone tumor that usually develops during the period of rapid growth which occurs in adolescence as a teenager matures into an adult.
Drugs associated with Osteosarcoma
The following drugs and medications are in some way related to, or used in the treatment of Osteosarcoma.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|---|---|---|
Adriamycin (More...) generic name: doxorubicin class: antibiotics/antineoplastics | 0 Review(s) | Not rated - Be the first |
| Rheumatrex (More...)generic name: methotrexate class: antimetabolites, antipsoriatics, antirheumatics | 0 Review(s) | Not rated - Be the first |
| Rheumatrex Dose Pack (More...)generic name: methotrexate class: antimetabolites, antipsoriatics, antirheumatics | 0 Review(s) | Not rated - Be the first |
| Trexall (More...)generic name: methotrexate class: antimetabolites, antipsoriatics, antirheumatics | 0 Review(s) | Not rated - Be the first |
Osteosarcoma Related Drugs in the Pipeline
L-MTP-PE (mifamurtide)
- August 27, 2007
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma - July 23, 2007
IDM Pharma Announces Plans to Amend New Drug Application for Mifamurtide (L-MTP-PE) for the Treatment of Patients with Osteosarcoma - May 9, 2007
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan (mifamurtide) for Treatment of Osteosarcoma - April 3, 2007
IDM Pharma Inc. Announces Oncologic Drugs Advisory Committee Meeting for Junovan (Mifamurtide) Will Take Place on May 9, 2007 - December 26, 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan (Mifamurtide) - October 26, 2006
IDM Pharma Submits New Drug Application to the FDA for Junovan (mifamurtide) in the Treatment of Osteosarcoma
See also
Learn more about Osteosarcoma
Medical encyclopedia results for:
